| BCBS Montana Medical Policies | Temporarily Implanted Nitinol Device (iTind) for Benign | 2026-04-01 |
| BCBS Montana Medical Policies | Teplizumab-mzwv | 2026-04-01 |
| BCBS Montana Medical Policies | Teprotumumab-trbw | 2026-04-01 |
| BCBS Montana Medical Policies | Tocilizumab and Associated Biosimilar(s) | 2026-04-01 |
| BCBS Montana Medical Policies | Triamcinolone acetonide | 2026-04-01 |
| BCBS Montana Medical Policies | Unicondylar Interpositional Spacer as a Treatment of | 2026-04-01 |
| BCBS Montana Medical Policies | Vedolizumab | 2026-04-01 |
| Medical Mutual | Lynozyfic™ (linvoseltamab-gcpt) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Penpulimab-KCQX (penpulimab-kcqx) (Intravenous) (EOV) | 2026-04-01 |
| Wellcare Kentucky Medicaid Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |